NasdaqCM - Delayed Quote • USD
ARCA biopharma, Inc. (ABIO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 4:33 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-5,014.0000
-5,014.0000
-10,912.0000
-18,762.0000
-7,725.0000
Investing Cash Flow
--
--
-2.0000
-43.0000
-19.0000
Financing Cash Flow
--
--
--
23,093.0000
48,452.0000
End Cash Position
37,431.0000
37,431.0000
42,445.0000
53,359.0000
49,071.0000
Interest Paid Supplemental Data
--
--
--
--
9.0000
Capital Expenditure
--
--
-2.0000
-43.0000
-19.0000
Issuance of Capital Stock
--
--
--
24,070.0000
50,894.0000
Free Cash Flow
-5,014.0000
-5,014.0000
-10,914.0000
-18,805.0000
-7,744.0000
12/31/2020 - 8/8/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHIO Phio Pharmaceuticals Corp.
0.6710
-4.25%
TENX Tenax Therapeutics, Inc.
3.5600
+0.85%
ASMB Assembly Biosciences, Inc.
13.48
+1.58%
ADIL Adial Pharmaceuticals, Inc.
1.7100
+0.59%
KTRA Kintara Therapeutics, Inc.
0.1373
+3.47%
PXMD PaxMedica, Inc.
0.6920
-3.35%
ACRV Acrivon Therapeutics, Inc.
9.50
-3.26%
CADL Candel Therapeutics, Inc.
6.05
+2.37%
EYEN Eyenovia, Inc.
0.5835
+7.54%
IBIO iBio, Inc.
1.9000
0.00%